Greg Zante

Chief Financial Officer

Chief Financial Officer at Viking Therapeutics, Inc., filing insider transactions on 2026-07-29.

Total Purchases

—

0 transactions

Total Sales

$710K

1 transaction

Companies Traded

1

1 total filings

Active Since

2026-07-29

Last: 2026-07-29

Companies

Viking Therapeutics, Inc.

Other Reporting Insiders at Viking Therapeutics, Inc.

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-07-29	VKTX	Sale	21.2K	$33.47	$710K	212.2K	SEC ↗

Greg Zante (Viking Therapeutics, Inc.) Insider Trades | Tormere